BCAA / Branched-Chain Amino Acids for Muscle Gain

Verdict: Isolated BCAA does not build muscle

High-quality reviews show that taking isolated BCAA supplements does not meaningfully increase muscle mass or strength; when overall protein intake is adequate, they add no extra benefit beyond complete protein.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

This claim earns a Counter-Evidence grade because the strongest available evidence points the same direction. A 2017 systematic review (PMID 28852372) concluded that the idea BCAAs alone stimulate muscle protein synthesis is "unwarranted," since BCAAs lack the other essential amino acids needed as building material. A 2021 review (PMID 33741748) likewise found that accumulated acute and long-term data do not support isolated BCAA or leucine as a meaningful strategy for hypertrophy or strength.

Newer syntheses agree. A 2025 systematic review of 22 trials (PMID 41346907) found only 1 of 5 body-composition studies showed muscle gains, calling the evidence inconsistent and equivocal. A 2024 overview of reviews (PMID 38241335) found BCAAs reduce post-exercise soreness and muscle-damage markers but provide no muscle-performance recovery benefit, and muscle gain was rarely even measured. A small crossover trial (PMID 28638350, n=10) showed a 22% rise in synthesis, but only versus placebo, not versus whole protein.

Regulators and clinics reinforce this. The EU's EFSA rejected all BCAA muscle and recovery claims for lack of an established cause-and-effect relationship, the US FDA lists BCAAs only as a safe nutrient supplement without any muscle health claim, and Mayo Clinic notes the precise role of BCAAs "remains to be defined" and that adequate dietary protein already meets needs.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.30
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
75%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.20
L3 MechanismPlausibility
0.25
L11 AI re-checkIndependent read
0.30
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.302
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 negative 主導 (2 negative > 0 positive),下層 RCT 不能推翻
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Branched-chain amino acids and muscle protein synthesis in humans: myth or reality?
PMID: 28852372 2017 系統性回顧
Finding: No human studies found quantifying oral BCAA effect on MPS; IV infusion studies showed BCAAs decreased both synthesis and breakdown; conclusion: claim that BCAA alone stimulates MPS is unwarranted.
🟢 High quality Mixed funding Effect size: theoretical max stimulation ~30% above basal, but unachievable without other EAAs
View on PubMed
Branched-Chain Amino Acid Ingestion Stimulates Muscle Myofibrillar Protein Synthesis following Resistance Exercise in Humans
PMID: 28638350 2017 RCT (double-blind) n = 10
Finding: Myofibrillar MPS was 22% higher with BCAA vs placebo (p=0.012; 0.110 vs 0.090 %/h), but study did not compare BCAA to complete/whey protein — the ~22% rise is vs placebo, not vs whole protein.
🟠 Limited quality Government Effect size: 22% above placebo; absolute rate 0.110 %/h BCAA vs 0.090 %/h PLA
View on PubMed
Isolated Leucine and Branched-Chain Amino Acid Supplementation for Enhancing Muscular Strength and Hypertrophy: A Narrative Review
PMID: 33741748 2021 系統性回顧
Finding: Despite early mechanistic support, accumulated acute and longitudinal evidence does not support isolated BCAA/leucine supplementation as a meaningful strategy for muscle hypertrophy or strength enhancement; EAAs including non-BCAA are required to sustain MPS.
🟢 High quality
View on PubMed
The Effect of Oral Pure Branched-Chain Amino Acid Supplementation on Exercise Performance and Body Composition: A Systematic Review
PMID: 41346907 2025 系統性回顧 n = 511
Finding: Only 1 of 5 body-composition studies (Muscella et al., n=100, 6 months) found significant muscle/FFM gains; 4 others showed no significant difference vs placebo; evidence for body composition improvements 'inconsistent' and 'equivocal'.
Academic Effect size: Muscella: muscle mass BCAA +2.2 kg vs placebo -0.6 kg (p<0.001); other 4 studies non-significant
View on PubMed
Branched-Chain Amino Acids Supplementation and Post-Exercise Recovery: An Overview of Systematic Reviews
PMID: 38241335 2024 系統性回顧
Finding: BCAA reduces CK (medium effects) and soreness (small effects) post-exercise; no effect on muscle performance recovery; muscle mass/muscle gain not assessed as outcome.
Effect size: CK: medium effect size; soreness: small-to-large effect sizes
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
NUTRIENT SUPPLEMENT source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
L-白胺酸(L-Leucine,編號095)、L-異白胺酸(L-Isoleucine,編號048)、L-纈胺酸(L-α胺基異戊酸/L-Valine,編號051)均列於「食品添加物使用範圍及限量暨規格標準」附表一第(八)類營養添加劑,使用食品範圍及限量:各類食品中視實際需要適量使用(以補充食品中不足之營養素為目的)。 source↗
L4e WHO
Not addressed
WHO/FAO/UNU Technical Report Series 935 (2007): Indispensable amino acid requirements for adults — leucine 39 mg/kg/day, isoleucine 20 mg/kg/day, valine 26 mg/kg/day (derived from 24-hour 13C leucine balance studies and body protein amino acid composition). source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
AAs stimulate protein synthesis and inhibit protein breakdown in skeletal muscle and liver. The specific role of BCAAs in regulating synthesis and breakdown of individual protein or proteins with common function or functions remains to be defined. source↗
L5c Cleveland Clinic
Cautious
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-muscle-gain-INT-branched-chain-amino-acids-001 繁體中文版 →